YUPELRI® net sales reached an all-time high of $71.4 million, recognized by Viatris, up 15% year-over-year 1 , and achieved record brand profitability ...

Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

Tech français consacré aux nouvelles technologies (internet, logiciel, matériel, mobilité, entreprise) et au jeu vidéo PC et consoles.

ETHZilla continues to hold approximately $400 million of ETH on its balance sheet to support future strategic initiatives.

Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary ...

Arbe Robotics Ltd. , a global leader in perception radar solutions, today announced that it will hold its third quarter 2025 conference call on Monday, November 17, 2025 at 8:30 a.m. Eastern Time. The ...

Faraday Future Launches FX Super One MPV in the UAE, with the AIHEREV Max edition priced at 309,000 AED; Soccer Legend Andrés Iniesta (Pictured Center) Named First Super One Owner and Co-Creation ...

Nov. 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company ... Enrollment in the Phase 3 XPORT-MM-031 trial (EMN29; NCT05028348) was completed ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...